Fabrice Gouilleux

CNRS Délégation Centre Poitou-Charentes

France

Research Interests

Explore related searches

Professors in France Professors in Cancer Biology Cancer Biology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Florence McCarthy

Lecturer

IRELAND

View details

Isabelle Ourliac-Garnier

Associate professor

Université de Nantes

FRANCE

View details

William Raoul

INSERM Délégation Régionale Grand Ouest

FRANCE

View details

Eric Largy

Assistant Professor

FRANCE

View details

Emmanuel GYAN

Professor of Hematology

Université de Tours Faculté de Médecine

FRANCE

View details

Pascal Marchand

Professor of Organic Chemistry (1st class)

Université de Nantes

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Fabrice Gouilleux

Research Interests

Explore related searches

Contact this professor

Articles (11)

Targeted Therapeutic Strategies for the Treatment of Cancer

Diphenyleneiodonium Triggers Cell Death of Acute Myeloid Leukemia Cells by Blocking the Mitochondrial Respiratory Chain, and Synergizes with Cytarabine

New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation

Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases

Design, synthesis, and antiproliferative effect of 2,9‐bis[4‐(pyridinylalkylaminomethyl)phenyl]‐1,10‐phenanthroline derivatives on human leukemic cells by targeting G‐quadruplex

Repurposing of Acriflavine to Target Chronic Myeloid Leukemia Treatment

Characterization of NADPH Oxidase Expression and Activity in Acute Myeloid Leukemia Cell Lines: A Correlation with the Differentiation Status

Horizontal meta-analysis identifies common deregulated genes across AML subgroups providing a robust prognostic signature

Inhibitors Targeting STAT5 Signaling in Myeloid Leukemias: New Tetrahydroquinoline Derivatives with Improved Antileukemic Potential

Acriflavine targets oncogenic STAT5 signaling in myeloid leukemia cells

VAS3947 Induces UPR-Mediated Apoptosis through Cysteine Thiol Alkylation in AML Cell Lines

Collaborators (6)

Florence McCarthy

Isabelle Ourliac-Garnier

William Raoul

Eric Largy

Emmanuel GYAN

Pascal Marchand

Make your next move.